Concepedia

Hilary P. Beck

HP

Statistics

Publications

11

Citations

939

H-Index

11

Active since

2007

Affiliations

Amgen (United States)(Current)

Hilary P. Beck is an author at Amgen (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

2007–2019

11

Publications

11

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 296 citations · Full text

, , +7

Structure-Based Design of Novel Inhibitors of the MDM2–p53 Interaction

Yosup Rew, Daqing Sun, Felix González-López de Turiso et al. · Journal of Medicinal Chemistry · 2012 · 169 citations · Full text

, , +14

Rational Design and Binding Mode Duality of MDM2–p53 Inhibitors

Felix González-López de Turiso, Daqing Sun, Yosup Rew et al. · Journal of Medicinal Chemistry · 2013 · 84 citations · Full text

, , +15

Selective and Potent Morpholinone Inhibitors of the MDM2–p53 Protein–Protein Interaction

Ana Z. González, John Eksterowicz, Michael D. Bartberger et al. · Journal of Medicinal Chemistry · 2014 · 83 citations · Full text

, , +8

A Selective Prostaglandin E<sub>2</sub> Receptor Subtype 2 (EP2) Antagonist Increases the Macrophage-Mediated Clearance of Amyloid-Beta Plaques

Brian M. Fox, Hilary P. Beck, Philip M. Roveto et al. · Journal of Medicinal Chemistry · 2015 · 61 citations · Full text

, , +17

1–5 of 11